More than 50 years of landmark results

Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.

Solutions for Complex Cases

Antitrust

Commodities

Data Privacy

Health Care

Securities

Professional Recommendations

“[Lowey Dannenberg] has considerable experience in litigating ‘some of the largest class actions throughout the country.’ . . . . The quality of their representation is also evidenced by the fact that Class Members, including sophisticated institutional investors, have not objected to the Settlement. The Court has no reason to doubt the quality of their representation.”

Hon. Gregory H. Woods, July 7, 2022 Fairness HearingTranscript, at p. 24 in In re JPMorgan Precious Metals Spoofing Litigation 18 Civ. 10356 (S.D.N.Y.)

“The court appreciates class counsel’s taking on these challenges and class counsel’s able navigation of these hard problems, in developing the case on behalf of the putative class, and in bringing contentious settlement negotiations to a successful outcome.

I might add too that the settlement was not only successful. Compared with many analogous cases, it was also prompt, a fact that brings obvious advantages to the class.”

Hon. Paul Engelmayer, May 31, 2022 Fairness Hearing Transcript, at p. 30 in In re JPMorgan Treasury Spoofing Litigation, 20 Civ. 3515 (S.D.N.Y.)

Recent Cases

Lopez v. Apple, Inc., No. 19-cv-04577 (N.D. Cal.)

Data Breach and Privacy, Data Privacy

By Christian Levis

Lowey Dannenberg serves as co-lead class counsel in a class action on behalf of consumers alleging that Apple unlawfully and intentionally recorded Plaintiffs’ and class members’ confidential communications without their […]

Read More

Shelled Eggs

Antitrust, Commodities

By Vincent Briganti

On June 8, Lowey Dannenberg Chairman Vincent Briganti was appointed as Co-Lead Counsel for the Direct Purchaser Plaintiffs in In Re: Shell Eggs Antitrust Litigation, No. 3:26-md-03175-JDP (W.D. Wisc.) Plaintiffs […]

Read More

Amitza

Healthcare

By Gerald Lawrence

Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. […]

Read More

News

Blog

SPAC Update

Sep 30, 2022

The special purpose acquisition company (“SPAC”) continues to have a profound impact on stock markets. We have written previously about the increasing popularity of SPAC’s and the risks inherent to SPAC’s. The SPAC device attempts to sidestep the SEC review process by bringing companies public...

Have a Case You Think We Can Help With?

Get Our Newsletter